Publisher's latest report MediPoint: Hip and Knee Reconstruction - Global Analysis and Market Forecasts provides insightful review and analysis on the hip and knee reconstruction market drivers, opportunities, restraints and challenges. The key questions answered in the report:

- Zimmer’s megamerger with Biomet in 2014 represents an attempt to lock in its dominance of the large joint space. How does the competitive landscape look like after the merger in different geographical regions?

- Given the escalating healthcare financial burden, many countries have put measures in place to initiate rationing of hip and knee replacements. How will the global hip and knee market evolve in the next five years?

While the hip and knee reconstruction market struggles to generate any significant growth in Europe and the US, hip and knee implants are increasingly being commoditized in developing economies such as Brazil, India, and China, and driving their respective markets at a rapid pace. The booming populations of Brazil, India, and China have a growing middle class that can afford a new quality of healthcare, and they are also gaining access to increased reimbursement.

As more training sessions take place in countries like China, where surgeons tend to devote more time to training compared with the US, there is promise for greater future adoption of techniques and products. There has been a slow and steady change in patients’ mentalities in developing countries, and more of the elderly are now willing to undergo the required joint replacement surgeries. Heightened public awareness will not only accelerate surgeons’ adoption of different types of implants, but will also effectively propel market growth.